August 9, 2023 is week 3, Yuansheng came to the big room early, Zhang Sheng said to him: "Recently, the hot spot has changed very quickly, can the pharmaceutical stocks that sprouted yesterday still play today?" ”

Yuansheng: "In the past two years, pharmaceutical stocks as a whole have been falling endlessly, and have become one of the hardest hit areas of A-shares, so the overall positioning of pharmaceutical stocks is now low, so some pharmaceutical stocks with first-class fundamentals can still continue to play." ”

Zhang Sheng: "It makes sense, if you want to play, you can play with first-class fundamentals." ...................................................................................................................................................................................................... ”

Yuansheng: "I found through a review that there is a stock with first-class fundamentals, after nearly 1 month of decline, it is already fallable!" It's Fengsheng stocks. ”

Yuansheng continued: "It has a lot of themes, please see ................................................."

Investor: What is the current progress of the Suzhou Science and Technology Plan project undertaken by your company: the R&D and industrialization of new targeted anti-cancer pharmaceutical heterobifunctional protein crosslinkers?

Company reply: Hello investors, the project is progressing in an orderly manner. Thank you for your question.

Investors: Which companies have you cooperated with in the research and development of ADC drugs in protein crosslinkers?

Company reply: Hello investors, please understand that the confidentiality agreements and confidentiality clauses of some of the company's customers prohibit the company from disclosing specific customer names and R&D projects.

Investor: Dear Secretary of the Board of Directors, can your company's downstream direction apply cosmetics and medical beauty?

Company reply: Hello investors, the company's peptide synthesis reagent products are mainly used in the synthesis of peptides and compounds containing amide bonds/peptide bonds. Downstream applications in the peptide industry include drugs, vaccines, cosmetic raw materials, etc. At present, the company's downstream customers are mainly concentrated in the pharmaceutical industry, and other industries account for a small proportion. Theoretically, if the beauty peptide product contains amide bonds/peptide bonds, and is synthesized by chemical synthesis, peptide synthesis reagents can be used, but at present, there are still very few beauty peptides synthesized by chemical synthesis. Thank you for your interest and questions.

Investors: Can the company's condensation reagent be used in the production of Eli Lilly's weight loss drug tirpatide? Whether the company's products have directly or indirectly entered Eli Lilly's supply chain.

The company replied: Hello investors, peptide synthesis reagents are widely used in the development and production of peptide drugs and small molecule chemical drugs containing amide bonds. The company serves nearly 2,000 customers every year, with many types and wide applications. Regarding the specific application of the company's products after the customer purchases, the downstream customers have their own confidentiality policies, and the specific application of which products involves the customer's trade secrets. Thank you for your interest.

Zhang Sheng sighed: "The theme of Fengsheng stocks is too rich, we will keep an eye on it at the opening and look for opportunities...................................................................................."

In the morning, Fengsheng stock opened 18.83% higher, and Yuansheng knew that the people who bought it yesterday earned more than 18% in one night, and there must be many people who were eager to cash out. Many people are eager to cash out, and the stock price will naturally fall, so Yuansheng is waiting for the opportunity to fall.........................................................................

At 9:45, Fengsheng stock retreated to the standard pair of 90.90 yuan, and Yuansheng said loudly: "Buy in large quantities!" ”

After the operation, Zhang Sheng asked: "Why buy in large quantities?" ”

Yuansheng: "Its fundamentals are so good, there is a high probability that it will not only rise for one day, so we buy on dips, and there is a high probability that we will be the winner!" So it's worth buying in bulk. ”

The 2nd battlefield is (written at night, 17K novel network can add words at any time)

.............................................................................................................................................................................................................. .................................

.............................................................................................................................................................................................................. ...................................

.............................................................................................................................................................................................................. .........................................